Navigation Links
Patients at high risk of recurrences of heart disease: Breakthrough in prevention
Date:5/20/2010

This press release is available in French.

Montreal, May 20, 2010 The results of a major clinical study carried out at the Montreal Heart Institute (MHI) by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit de Montral.

The promising findings of this study on VIA-2291 a medication developed by Via Pharmaceuticals, a San Francisco-based biotechnology firm relate to its capacity to effectively reduce inflammation, which can contribute to the formation and progression of atherosclerosis plaque and infarct.

"Up to now, standard treatments for patients with acute coronary syndrome (unstable angina and infarct) have not specifically reduced inflammation, an important component of atherosclerosis. However, research in recent years has allowed us to determine that the presence of inflammation significantly increases the risk of recurrence among these patients. The clinical study was conducted with about 200 patients, and the findings we're publishing show that VIA-2291 may finally offer the solution we need to target and reduce inflammation. In fact, these newly published data strongly support the evaluation of VIA-2291 in larger outcome trials," said Dr. Tardif.

The Montreal Heart Institute's Research Centre directed the study in several hospitals in Canada and the United States as well as analyzed all of the data, including data collected by CAT scans of coronary arteries.

"The publication of this new study attests once again to the excellence of the entire team at the Montreal Heart Institute's Research Centre. While we're clearly satisfied with the findings obtained with VIA-2291, we're even more thrilled at the prospect of taking a big step toward more effective and personalized prevention of cardiovascular disease," concluded Dr. Tardif.


'/>"/>

Contact: Rachel Ladouceur-Girard
rachel.ladouceur-girard@icm-mhi.org
514-376-3330, x 2641
University of Montreal
Source:Eurekalert

Related medicine news :

1. When Heart Patients Discharge Themselves, Hospital Bills Increase
2. A useful tool to detect in vivo angiogenesis in IBD patients: Narrow-band imaging
3. Older patients offer insight into the future of cystic fibrosis
4. Depressed chronic kidney disease patients more likely to face complications
5. First study examines postpolypectomy bleeding in colonoscopy patients on uninterrupted clopidogrel
6. POP ROCK BAND Honor Society Drummer Advocates for Inflammatory Bowel Disease Patients on Capitol Hill in Conjunction with World IBD Day
7. Older Patients More Apt to Be Happy With Plastic Surgery
8. Oncolytic viruses mediating anti-tumor immunity in human cancer patients
9. What Doctors Won't Tell Their Patients About Cancer
10. Well-tolerated radiotherapy provides longer life to patients with recurrent brain cancer
11. Challenging the use of routine repeated chest X-rays in certain patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... ... a new educational seminar to focus on current legislative activity and the latest ... begin at 1 p.m. Sunday, Sept. 10, and will continue through Monday, Sept. ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community ... healthiest seniors are located in the Midwest. With the average cost of healthcare rising ... are concerned with both the quality and affordability of where they live. An annual ...
(Date:5/26/2017)... BOSTON, MA (PRWEB) , ... May 26, 2017 , ... ... Care Act (AHCA), which narrowly passed the U.S. House on May 4, would result ... would be expected under continued implementation of the 2010 Patient Protection and Affordable Care ...
(Date:5/26/2017)... ... 2017 , ... Silver Birch of Hammond, a new assisted lifestyle community, has ... acres of land at 5620 Sohl Avenue in Hammond, serves older adults who need ... studio and one-bedroom apartments. Each of the private apartments at Silver Birch features a ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: a poignant story ... published author Laura Weigel Douglas, an avid reader who lives in the Pacific Northwest ... feels like Green Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year old ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... May 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of ... Canadian Intellectual Property Office has granted Oramed a ... of Exenatide". The patent covers Oramed,s invention of ... GLP-1 is an incretin hormone that stimulates the ...
(Date:5/6/2017)... , May 5, 2017   Provista , a proven ... than 200,000 customers, today announced Jim Cunniff as ... of executive and business experience to Provista, including most recently ... in California . He assumed his new ... is a great fit for Provista," says Jody Hatcher ...
(Date:5/4/2017)...  A recent study published in the American ... as a means of disinfection anesthesia workstations ... on anesthesia workstations. In the study, UVC disinfection ... equipment surfaces contaminated with three (3) organisms commonly ... further validates the body of literature supporting Tru-D," ...
Breaking Medicine Technology: